Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06802978

Lipid Profile in Diabetic and Non Diabetic CKD Patients

The goal of this observational study is to compare blood lipid (fat) levels in participants with chronic kidney disease (CKD) with diabetes and without diabetes and who over 20 years old.

The main question this study aims to answer is:

Does having diabetes make fat problems worse in people with chronic kidney disease (CKD), or is there no connection between them?

Researchers will compare the blood lipid (fat) levels in people with chronic kidney disease (CKD) who have diabetes and those without diabetes to see if having diabetes makes lipid problems worse in CKD patients, or if there is no connection between diabetes and changes in lipid levels.

Participants will need to fast for 10 hours before undergoing this test. This means not eating any food or drinking anything except water.

Samples will be taken and sent to laboratory immediately.

Recruiting

Interested in participating?

Request Info

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Internal Medicine , Sohag University Hospital.

Sohag, Egypt

Location status: Recruiting

Location contact

Mahmoud Ibrahim Yousef

CONTACT

+201065964083

Shaimaa Mahmoud Elsayed Abdel-Raheem

CONTACT

[email protected]

+201119193276

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients of chronic kidney disease (CKD) presenting to the Sohag University Hospital
  • Patients aged above 20 years of age.
  • All patients who have given consent for enrolling into the study.

Exclusion criteria

  • Patients aged 20 years of age or below.
  • Patients on lipid-lowering drugs.
  • Kidney transplanted patients.

Treatment and study plan

Primary outcomes

  1. Assessment and comparison of the lipid profile between diabetic and non-diabetic chronic kidney disease patients using the colorimetric method on a fully automated biochemistry analyser.

    Time frame: January 2025 to January 2026.

    Lipid profile were assessed in samples of chronic kidney disease patients , both with diabetes and without diabetes, after obtaining informed consent to compare lipid profile between these two groups.

    Overnight fasting samples were taken and sent to the laboratory immediately. Serum was separated within 2 hours after collection to prevent artifactual changes in the concentration of HDL. After clot retraction occurred, the serum was transferred to a centrifuge tube and centrifuged at 2000 rpm for 5 minutes. The clear supernatant serum was then pipetted out using dry piston pipettes with disposable tips and stored in dry thin walled vials at 4°C. The samples were analyzed on the same day.

    The following parameters were analyzed using the colorimetric method on a fully automated biochemistry analyser.

    • Serum Cholesterol
    • Serum Triglyceride
    • Serum HDL (high-density lipoprotein)
    • Serum LDL ( low-density lipoprotein)
    • Serum VLDL (very low-density lipoprotein)

Study contacts

Contact information is provided by the study sponsor or research team.

Mahmoud Ibrahim Yousef

CONTACT

+201065964083

Shaimaa Mahmoud Elsayed Abdel-Raheem

CONTACT

[email protected]

+201119193276

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Study of Lipid Profile in Diabetic and Non Diabetic Chronic Kidney Disease Patients in Sohag University Hospital

Acronym: CKD

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 31, 2025
Registry last updated
Jun 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.